Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide

Bone Marrow Transplantation, Published online: 05 January 2024; doi:10.1038/s41409-023-02189-9Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide

Source: Bone Marrow Transplantation - January 5, 2024 Category: Hematology Authors: Niveditha Ravindra Laura W. Dillon Gege Gui Matthew Smith Lukasz P. Gondek Richard J. Jones Adam Corner Christopher S. Hourigan Alexander J. Ambinder Source Type: research